Cogniss partners with ORCHA to unlock the next generation of digital health
From left: Senator the Hon Don Farrell, Fiona Costello, Dr Lloyd Humphreys
It is estimated that only 20% of the over 350k health apps in the market meet safety standards. Why? The pathway to meeting compliance standards is incredibly complex within a single country, let alone worldwide. Not only are health app creators faced with the pressure of creating an innovative solution, but they are also required to meet country-specific regulations and standards.
To address this gap in the market, Cogniss and ORCHA, a UK-based world leader in digital health evaluation and distribution, have decided to become partners. This global partnership is formed at the right time, just as the new UK-Australian Free Trade Agreement (FTA) was passed through the UK House of Commons and is anticipated to come into effect in 2023.
With this new collaboration, apps created through our no-code platform will meet ORCHA’s Baseline Review standards in terms of data, security and accessibility. This will streamline the app creation and evaluation process, and reduce the barriers and complexities associated with launching safe and effective health apps — which are issues that hinder solutions from making their way into government healthcare insurance schemes like Medicare and public healthcare systems like the UK’s National Health Service (NHS).
During last week’s event at the Australian High Commission hosted by Senator the Hon Don Farrell, ORCHA’s Accreditations SVP, Fiona Costello, shared, “We are often approached by clinicians with solutions to the problems they are facing, but they lack the time, resources and expertise to build them, therefore relying on commercial products that are not always a perfect fit. Alongside Cogniss, we can now help them to understand the criteria to create high-quality technologies and, through this partnership, support them to develop market-ready solutions.”
Cogniss’s newly appointed Managing Director, Dr. Lloyd Humphreys, said, “Having founded and created a digital health solution for addictions back in 2009, it took over two years and a million pounds of investment. Since then, nothing has changed in the way we design and create apps. Cogniss represents a complete paradigm shift for the sector and working with ORCHA further accelerates the ability to lower the barriers for clinical entrepreneurs to create great technology that solves the challenges they are facing.”
We look forward to working with ORCHA as we currently set up our global headquarters in Cambridge with support from the UK Department for International Trade, Investment NSW and Austrade.